Luye Pharma Group Limited — Earnings Release 2003

Nov 21, 2002

Listed Company Information

TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 21/11/2002: (stock code: 00918 ) Year end date: 31/03/2003 Currency: HKD Auditors' Report: N/A Review of Interim Report by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/04/2002 from 01/04/2001 to 30/09/2002 to 30/09/2001 Note ('000 ) ('000 ) Turnover : 231,906 164,658 Profit/(Loss) from Operations : 10,540 4,041 Finance cost : (1,279) (2,892) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 0 137 Profit/(Loss) after Tax & MI : 9,393 1,690 % Change over Last Period : +456 % EPS/(LPS)-Basic (in dollars) : 0.0241 0.0043 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 9,393 1,690 Interim Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: Note: (1) Earnings per share The calculation of basic earnings per share is based on the Group's profit attributable to shareholders of HK$9,393,000 (2001: HK$1,690,000) for the period and on the weighted average number of 389,500,000 (2001: 395,139,344) ordinary shares in issue during the period. No information in respect of diluted earnings per share is presented for the six months ended 30th September, 2002 and 2001 as there is no dilutive potential ordinary share for these periods.